13171-25-0

Trimetazidine Dihydrochloride is a fatty acid oxidation inhibitor as an anti-ischemic (anti-anginal) metabolic agent, improving myocardial glucose utilization through inhibition of fatty acid metabolism and and preventing macrophage-mediated septic myocardial dysfunction via activation of the histone deacetylase sirtuin.